Skip to content

Hematrak Abnormal Recognition

by Geometric Data, Div. Smithkline Corp.

510(k) K791041

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK791041 Date4 Sep 1979ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GKZ
Device Class
Class II
Regulation
21 CFR Part 864.5220
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Hematrak Abnormal Recognition is a hematology device used for the recognition of abnormal cells. It is classified as a Counter, Differential Cell device and is designed for use in hematology laboratories.

The device is manufactured by Geometric Data, Div. Smithkline Corp. and received FDA 510(k) clearance with number K791041 on September 4, 1979. It is a Class II device with product code GKZ and is intended for laboratory use. The device is not specified as single-use or reusable, and no information regarding sterility, MRI safety, or storage conditions is provided.

Other devices from Geometric Data, Div. Smithkline Corp.

See all devices from Geometric Data, Div. Smithkline Corp. →

Questions

AI-generated answers, 24 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the HEMATRAK Abnormal Recognition device used for?

    The HEMATRAK Abnormal Recognition is a hematology device designed for the recognition of abnormal cells in laboratory settings. It is classified as a Counter, Differential Cell device and is intended for use in hematology laboratories to assist in cell identification and analysis.

  • Is the HEMATRAK Abnormal Recognition device single-use or reusable?

    The device information does not specify whether the HEMATRAK Abnormal Recognition is designed for single-use or multiple reuse. This detail is not provided in the available documentation, so users should consult the manufacturer's instructions for specific guidance on usage and disposal protocols.

  • What regulatory approvals does the HEMATRAK Abnormal Recognition have?

    The HEMATRAK Abnormal Recognition received FDA 510(k) clearance with number K791041 on September 4, 1979. It is classified as a Class II device with product code GKZ and is intended for laboratory use. The device is manufactured by Geometric Data, Div. Smithkline Corp.

  • What are the specifications of the HEMATRAK Abnormal Recognition device?

    The HEMATRAK Abnormal Recognition is a hematology device classified as a Counter, Differential Cell device. It has product code GKZ and is a Class II device. The device is designed for laboratory use and received FDA clearance through the traditional 510(k) pathway, with a decision description of 'Substantially Equivalent'.